Publications

View the publications of the Amsterdam UMC Pigment cell research team at:
Pubmed.

Below you will find the 20 most recent publications:

• Revealing biological mechanisms of skin pigment recovery during treatment in vitiligo patients: A proteomic analysis
• Exploring novel skin biomarkers related to pruritus in dialysis patients
• Immune and Biological Changes during Treatment in Patients with Nonsegmental Vitiligo and their Relation to Repigmentation
• Vitiligo-associated protection against basal cell carcinoma: Clinical observations
• Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma
• Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy
• Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapy
• Regulatory T Cell Dysfunction in Autoimmune Diseases
• Addition of cell suspension transplantation to UVB and topical treatment in non-segmental vitiligo: a randomized controlled study
• Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients
• The Risk of Keratinocyte Cancer in Vitiligo and the Potential Mechanisms Involved
• Trained immunity in the pathogenesis of vitiligo
• Lower Skin Cancer Risk in Vitiligo: DNA Repair as Potential Mechanism?
• NB-UVB phototherapy response of different body regions in non-segmental vitiligo
• Presence of Skin Tissue-Resident Memory T Cells in Human Nonmalignant and Premalignant Melanocytic Skin Lesions and in Melanoma
• IFN-γ-induced PD-L1 expression on human melanocytes is impaired in vitiligo
• A secondary role for hypoxia and HIF1 in the regulation of (IFNγ-induced) PD-L1 expression in melanoma
• Immunophenotypic Analysis Reveals Differences in Circulating Immune Cells in the Peripheral Blood of Patients with Segmental and Nonsegmental Vitiligo
• Does autoimmune vitiligo protect against COVID-19 disease?
• Vitiligo induced by immune checkpoint inhibitors in melanoma patients: an expert opinion